Shanghai (1)

ALK-negative Anaplastic Large Cell Lymphoma (1)

Angioimmunoblastic T Cell Lymphoma (1)

Enteropathy Associated T Cell Lymphoma (1)

Hepatosplenic T Cell Lymphoma (1)

Peripherial T Cell Lymphoma,Not Otherwise Specified (1)

Subcutaneous Panniculitis Like T Cell Lymphoma (1)

Unknown status (1)

phase 4 (1)

Ruijin Hospital (1)

cyclophosphamide 750mg/m2 (1)

doxorubicin 50mg/m2 (1)

etoposide phosphate 100mg/m2 (1)

ifosfamide 2000mg/m2 (1)

methotrexate 1500mg/m2 (1)

pirarubicin 25mg/m2 (1)

pirarubicin 50mg/m2 (1)

prednisone 60mg/m2 (1)

vincristine 1.4mg/m2 (1)

drug (1)

Other (1)

Interventional (1)

Hepatosplenic T Cell Lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Unknown status

Nov 10, 2017